Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

COUCH Medcomms

- PMLiVE

Nucleus Global launches Nucleus X Consulting, a specialist consultancy with deep expertise in patient engagement, rare disease, and early-phase medical commercialization

Nucleus Global, the largest specialist medical communications network in the world, announces the launch of a new consultancy to add to its family of agencies. Nucleus X Consulting consists of...

Nucleus Global

- PMLiVE

Merck’s Keytruda receives FDA approval for advanced endometrial cancer

The approval was based on new data from the KEYNOTE-158 trial

- PMLiVE

FDA to review requirements for future booster shots for COVID-19

The meeting will be streamed live on the FDA’s YouTube channel and a webcast will be provided on the FDA website

Top 10 Most Common Participant Comments – Online Advisory Boards

What advisors and participants have to say about the Impetus InSite Platform!

Impetus Digital

KVA header image and David Rowley

Healthcare services entrepreneur David Rowley joins KVA

KVA appoints David Rowley to act as advisor to the board

KVA

Engaging doctors around the globe

Embedding a digital strategy as a prominent part of a pharmaceutical marketing campaign is becoming ever more important. Despite some perceived reluctance on the part of the industry, pharmaceutical companies...

M3 (EU)

- PMLiVE

Moderna applies to FDA for authorisation for second COVID-19 booster shot for all adults

The second booster shot would be for adults 18 years and over who have already had one authorised COVID-19 booster shot

- PMLiVE

CBI launches new Health Council as part of its Seize The Moment 2030 vision

The CEO forum has been designed to bring together business, government and civil society to improve health outcomes across the UK

OPEN Health - David Thompson

David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access

David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access

OPEN Health

- PMLiVE

AstraZeneca’s Alexion agrees on $775m settlement with Chugai for Ultomiris

The two companies will withdraw patent infringement proceedings filed with the US and Japan

- PMLiVE

Merck KGaA to make $3m payout to patients after drug formulation complaints

La Cour de Cassation has ordered the company to make the payment to more than 3,000 patients to settle the reformulation dispute

Top 10 Ways that Medical Affairs Team Can Leverage the Impetus Insite Platform

New to asynchronous touchpoints? Don’t know where to start? Need help designing an asynchronous event that will engage your stakeholders and give you the insights you’re looking for? In addition...

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links